Algal extract for use in the treatment or prevention of post-traumatic immunosuppression
US12377126B2 · kind B2 · utility
0Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2019 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Nov 8, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2236/53
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is an extract of algae of the order Ulvales, including sulfated and non-sulfated polyanionic polysaccharides, the molecular weight of which is less than or equal to 50 kDa, for use in the prevention and/or treatment of complications caused by post-traumatic immunosuppression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.